In this study, We report on the use of fluorine 18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) scan examinations for detecting potential COVID-19 respiratory syndrome in asymptomatic left ventricular assist device (LVAD) recipients. Thus, extreme caution and thoughtful approaches should be taken for a timely detection in delicate LVAD populations, especially if patients are living in a high-density COVID-19-infected area, and the potential intention for LVAD treatment is bridge to transplantation.
Contributory role of positron emission tomography in a left ventricular assist device recipient at the time of COVID-19 pandemic
Loforte A.
First
;
2020-01-01
Abstract
In this study, We report on the use of fluorine 18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) scan examinations for detecting potential COVID-19 respiratory syndrome in asymptomatic left ventricular assist device (LVAD) recipients. Thus, extreme caution and thoughtful approaches should be taken for a timely detection in delicate LVAD populations, especially if patients are living in a high-density COVID-19-infected area, and the potential intention for LVAD treatment is bridge to transplantation.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
mat-publish-ahead-of-print-10.1097.mat.0000000000001176.pdf
Accesso riservato
Dimensione
347.97 kB
Formato
Adobe PDF
|
347.97 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
